Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

Xiaoran Yin; Yan Feng; Bowen Zhang; Xueyan Mao; Siying Chen; Yuyan Wang; Sidney W Fu

doi:10.3389/fonc.2023.1301340

Editorial: Tumor immune microenvironment topographies for prediction and evaluation: unlock the mystery of the therapeutic effects and adverse events of tumor immunotherapy

Front Oncol. 2023 Nov 1:13:1301340. doi: 10.3389/fonc.2023.1301340. eCollection 2023.

Authors

Xiaoran Yin¹, Yan Feng², Bowen Zhang¹, Xueyan Mao³, Siying Chen⁴, Yuyan Wang⁵, Sidney W Fu⁶

Affiliations

¹ Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
² Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
³ Department of Medical Intensive Care Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
⁴ Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
⁵ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
⁶ Division of Cancer Prevention (Cancer Biomarkers Research Group), National Cancer Institute, Rockville, MD, United States.

No abstract available

Keywords: computational technology; immune landscape; prognostic model; tumor immunotherapy; tumor microenvironment.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (NSFC) (81802453), the Key Research and Development Program of Shaanxi Province (2019SF-093), and the Basic Scientific Research Interdisciplinary and Cooperation Project of Xi’an Jiaotong University (1119293853).